<VariationArchive RecordType="classified" VariationID="988027" VariationName="NM_000485.2:c.-1_*1del" VariationType="Deletion" Accession="VCV000988027" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-10-30" DateCreated="2020-12-11" MostRecentSubmission="2020-12-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="975954" VariationID="988027">
      <GeneList>
        <Gene Symbol="APRT" FullName="adenine phosphoribosyltransferase" GeneID="353" HGNC_ID="HGNC:626" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="88809339" stop="88811928" display_start="88809339" display_stop="88811928" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="88875876" stop="88878341" display_start="88875876" display_stop="88878341" Strand="-" />
          </Location>
          <OMIM>102600</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000485.2:c.-1_*1del</Name>
      <VariantType>Deletion</VariantType>
      <Comment DataSource="NCBI curation" Type="GenomicLocationNotEstablished">The genomic location for this variant will not be computed from alignment of the transcript sequence to the genome until there is experimental evidence for the genomic basis of the deletion.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000485.2:c.-1_*1del AND Adenine phosphoribosyltransferase deficiency" Accession="RCV001269419" Version="1">
        <ClassifiedConditionList TraitSetID="8113">
          <ClassifiedCondition DB="MedGen" ID="C0268120">Adenine phosphoribosyltransferase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-09-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-12-11" MostRecentSubmission="2020-12-11">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1353080</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8113" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6494" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Adenine phosphoribosyltransferase deficiency</ElementValue>
                <XRef ID="MONDO:0013869" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">UROLITHIASIS, 2,8-DIHYDROXYADENINE</ElementValue>
                <XRef Type="MIM" ID="614723" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NEPHROLITHIASIS, DHA</ElementValue>
                <XRef Type="MIM" ID="614723" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dihydroxyadeninuria</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">APRTD</ElementValue>
                <XRef Type="MIM" ID="614723" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Adenine phosphoribosyltransferase (APRT) deficiency is characterized by excessive production and renal excretion of 2,8-dihydroxyadenine (DHA), which leads to kidney stone formation and crystal-induced kidney damage (i.e., DHA crystal nephropathy) causing acute kidney injury episodes and progressive chronic kidney disease (CKD). Kidney stones, the most common clinical manifestation of APRT deficiency, can occur at any age; in at least 50% of affected persons symptoms do not occur until adulthood. If adequate treatment is not provided, approximately 20%-25% of affected individuals develop end-stage renal disease (ESRD), usually in adult life.</Attribute>
                <XRef ID="NBK100238" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22934314</ID>
                <ID Source="BookShelf">NBK100238</ID>
              </Citation>
              <XRef ID="976" DB="Orphanet" />
              <XRef ID="C0268120" DB="MedGen" />
              <XRef ID="MONDO:0013869" DB="MONDO" />
              <XRef Type="MIM" ID="614723" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2861979" SubmissionDate="2020-11-13" DateLastUpdated="2020-12-11" DateCreated="2020-12-11">
        <ClinVarSubmissionID localKey="NM_000485.2:c.-1_*1del|OMIM:614723" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001449056" DateUpdated="2020-12-11" DateCreated="2020-12-11" Type="SCV" Version="1" SubmitterName="APRT Deficiency Research Program of the Rare Kidney Stone Consortium, Landspitali, National University Hospital of Iceland" OrgID="507801" OrganizationCategory="patient registry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">1353080</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APRT" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000485.2:c.-1_*1del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614723" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8542258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2861979" TraitType="Disease" MappingType="XRef" MappingValue="614723" MappingRef="OMIM">
        <MedGen CUI="C0268120" Name="Adenine phosphoribosyltransferase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

